Arcus Biosciences (RCUS) Shares Outstanding (Entity) (2017 - 2026)

Arcus Biosciences (RCUS) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Arcus Biosciences 3.74 Bn 3.04 Bn - 127.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 127.00 Mn
Mar 31, 2026 125.50 Mn
Dec 31, 2025 125.30 Mn
Sep 30, 2025 107.10 Mn
Jun 30, 2025 106.40 Mn
Mar 31, 2025 105.90 Mn
Dec 31, 2024 92.20 Mn
Sep 30, 2024 91.50 Mn
Jun 30, 2024 91.30 Mn
Mar 31, 2024 90.90 Mn
Dec 31, 2023 75.50 Mn
Sep 30, 2023 74.80 Mn
Jun 30, 2023 74.50 Mn
Mar 31, 2023 73.10 Mn
Dec 31, 2022 72.90 Mn
Sep 30, 2022 72.35 Mn
Jun 30, 2022 72.09 Mn
Mar 31, 2022 71.62 Mn
Dec 31, 2021 70.78 Mn
Sep 30, 2021 70.24 Mn